TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Total Assets

Annual figures by fiscal year, from SEC filings.

2015: $98.46M2016: $140.15M2017: $94.78M2018: $118.23M2019: $83.65M2020: $85.53M2021: $109.45M2022: $68.24M2023: $45.55M2024: $68.91M2025: $71.12M$71.12M
2015Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$71.12M+3.2%
2024$68.91M+51.3%
2023$45.55M-33.2%
2022$68.24M-37.7%
2021$109.45M+28.0%
2020$85.53M+2.3%
2019$83.65M-29.3%
2018$118.23M+24.8%
2017$94.78M-32.4%
2016$140.15M+42.3%
2015$98.46M—